MACROBID

This brand name is authorized in Canada, Ireland, Israel, New Zealand, United Kingdom, United States

Active ingredients

The drug MACROBID contains one active pharmaceutical ingredient (API):

1 Nitrofurantoin UNII 927AH8112L - NITROFURANTOIN

Nitrofurantoin is a broad spectrum antibacterial agent, active against the majority of urinary pathogens. It is bactericidal in renal tissue and throughout the urinary tract. The wide range of organisms sensitive to the bacterial activity include Escherichia coli, Enteroccus faecalis, Klebsiella species, Enterobacter species, Staphylococcus species: (e.g. S. aureus, S. saprophyticus, S. epidermidis). Read about Nitrofurantoin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
MACROBID Capsule	FDA, National Drug Code (US)	MPI, US: SPL/Old
MACROBID Prolonged-release capsule	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01XE01	Nitrofurantoin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01X Other antibacterials → J01XE Nitrofuran derivatives
Discover more medicines within J01XE01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02063662
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 23528, 373882
Country: IE	Health Products Regulatory Authority	Identifier(s): 32457
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 9371
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 18057
Country: US	FDA, National Drug Code	Identifier(s): 52427-285, 70518-2531